Legal challenges put off label use of gender affirming care drugs in jeopardy
Pharmaceutical Technology
MARCH 16, 2023
Most drugs used here are prescribed off-label, and experts say pharmaceutical companies remain hesitant to conduct clinical trials studying gender-affirming care. One of the reasons why organisations, including pharma companies, do not enter this debate is because these drugs are used off label, says Horowicz.
Let's personalize your content